Quality-of-life outcomes for men treated with cryosurgery for localized prostate carcinoma

Cancer

Volumn 86, Issue 9, 1999, Pages 1793-1801

  Robinson, John W ^a,b   Saliken, John C ^a,c   Donnelly, Bryan J ^a,c   Barnes, Penny ^b   Guyn, Lindsay ^d  

^a UNIVERSITY OF CALGARY   (Canada)

^b TOM BAKER CANCER CENTRE   (Canada)

^c CALGARY HEALTH REGION   (Canada)

^d Guyn Cooper Research Associates   (Canada)

Author keywords

Cryosurgery; Prostate carcinoma; Quality of life; Radical prostatectomy; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRYOSURGERY; FOLLOW UP; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATECTOMY; QUALITY OF LIFE; SEXUAL FUNCTION; TREATMENT OUTCOME;

AGED; APPETITE; CRYOSURGERY; DEFECATION; HUMANS; MALE; MIDDLE AGED; PAIN; PHYSICIAN-PATIENT RELATIONS; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; QUALITY OF LIFE; SEXUAL BEHAVIOR; TIME FACTORS; URINATION;

EID: 0033230337     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19991101)86:9<1793::AID-CNCR22>3.0.CO;2-J     Document Type: Article

References (30)

1. National Cancer Institute of Canada. Canadian cancer statistics, 1996. Toronto, 1996.
2. Boring CC, Squires TS, Tong T, Montgumery S. Cancer statistics, 1994. CA Cancer J Clin 1994;44:7-26.
3. Litwin MS, Hays RD, Fink A, Ganz P, Leake B, Leach G, et al. Quality-of-life outcomes in men treated for prostate cancer. JAMA 1995;273:129-35.
4. Lim AJ, Brandon AH, Fiedler J, Brickman A, Boyer C, Raub W, et al. Quality of life: radical prostatectomy versus radiation therapy for prostate cancer. J Urol 1995;154:1420-5.
5. Fowler FJ, Barry MJ, Lu-Yao G, Roman A, Wasson J, Wennberg JE. Quality of life assessment in patients with prostate cancer treated by radical prostatectomy, radiation therapy or a combination. Urology 1993;42:622-9.
6. Shrader-Bogen CL, Kjellberg JL, McPherson CP, Murray CL. Quality of life and treatment outcomes. Cancer 1998;79: 1977-86.
7. Wieder J, Schmidt G, Casola E, van Sonnenberg E, Stainken BF, Parsons CL. Transrectal ultrasound-guided transperineal cryoablation in the treatment of prostate carcinoma: preliminary results. J Urol 1995;154:435-41.
8. Gondor MJ, Soanes WA, Shulman S. Cryosurgical treatment of the prostate. Investig Urol (Berl) 1966;3:372-8.
9. Bonney WW, Fallon B, Gerber WL, Hawtrey C, Loening SA, Narayana AS. Cryosurgery in prostatic cancer: survival. Urology 1982; XIX:37-42.
10. Onik G, Porterfield B, Rubinsky B, Cohen J. Percutaneous transperineal prostate cryosurgery using transrectal ultrasound guidance: animal model. Urology 1991;XXXVII:277-81.
11. Cox RL, Crawford ED. Complications of cryosurgical ablation of the prostate to treat localized adenocarcinoma of the prostate. Urology 1995;45:932-5.
12. Wong WS, Chinn DO, Chinn M, Chinn J, Rom WL, Wynnmian LT. Cryosurgery as a treatment for prostate carcinoma. Cancer 1997;79:963-74.
13. Loening S, Hawtrey C, Bonney W, Narayana A, Culp DA. Cryotherapy of prostate cancer. Prostate 1980;1:279-86.
14. Loening S, Lubaroff D. Cryosurgery and immunotherapy for prostatic cancer. Urol Clin North Am 1984; 11:327-36.
15. Grampsas SA, Miller GJ, Crawford ED. Salvage radical prostatectomy after failed transperineal cryotherapy: histologic findings from prostate whole-mount specimens correlated with intraoperative transrectal ultrasound images. Urology 1995;45:936-41.
16. Pisters LL, VonEschenbach AC, Scott SM, Swanson DA, Dinney CP, Pettaway CA, et al. The efficacy and complications of salvage cryotherapy of the prostate. J Urol 1997;157: 921-5.
17. Patel BG, Parsons CL, Bidair M, Schmidt JD. Cryoablation for carcinoma of the prostate. J Surg Oncol 1996;63:256-64.
18. Litwin MS, Lubeck DP, Henning JM, Carroll PR. Differences in urologist and patient assessments of health related quality of life in men with prostate cancer: results of the capsure database. J Urol 1998;159:1988-92.
19. Fowler FJ Jr., Barry MJ, Lu-Yao G, Wasson J, Roman A, Wennberg J. Effect of radical prostatectomy for prostate cancer on patient quality of life: results from a medicare survey. Adult Urol 1995;45:1007-15.
20. Saliken JC, Donnelly BJ, Brasher P, Ali-Ridha N, Robinson J., Ernst, S. The outcome and safety of TRUS-guided percutaneous cryotherapy for localized prostate cancer. J Vasc Interv Radiol 1999;10:199-208.
21. Roach M. Equations for predicting the pathological stage of men with localized prostate cancer using preoperative prostate antigen (PSA) and Gleason score. J Urol 1993;150:1923.
22. Onik GM, Cohen JK, Reyes GD, Rubinsky B, ZhoaHua C, Baust J. Transrectal ultrasound-guided percutaneous radical cryosurgical ablation of the prostate. Cancer 1993;72:1291-9.
23. Cella D. F.A.C.T. Manual. Manual Functional Assessment of Cancer Therapy (FACT) Scales and the Functional Assessment of HIV Infection (FAHI) Scale, Version 3. 1-25. 7-1-1994.
24. Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bononi A, Silberman M, Yellen S, Winicour P, Brannon J. The Functional Assessment of Cancer Therapy Scale: Development and Validation of the General Measure. J Clin Oncol 1993; 11:570-9.
25. Esper P, Mo F, Chodak G, Sinner M, Cella D, Pienta KJ. Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument. Urology 1997;50:920-8.
26. Osoba D. Measuring the effect of cancer on quality of life. London: CRC Press, 1991:25-40.
27. Watkins-Bruner D, Scott C, Lawton C, Del Rowe J, Rotman M, Buswell L, et al. RTOG's first quality of life study, RTOG 90-20: a Phase II trial of external beam rdiation with etanidazole for locally advanced prostate cancer. Int J Radiat Oncol Biol Phys 1995;33:901-6.
28. Shinohara K, Connolly JA, Presti JC, Carroll PR. Cryosurgical treatment of localized prostate cancer (stages T1 to T4): preliminary results. Journal Urol 1996;156:115-21.
29. Bahn DK, Lee F, Solomon MH, Gontina H, Klionsky DL, Lee FT Jr. Prostate cancer: US-guided percutaneous cryoablation. Radiology 1995;194:551-6.
30. Robinson JW, Dufour MS, Fung TS. Erectile functioning of men treated for prostate carcinoma. Cancer 1996;79:538-44.